These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 23228201

  • 41. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder.
    Vieta E, Montgomery S, Sulaiman AH, Cordoba R, Huberlant B, Martinez L, Schreiner A.
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488
    [Abstract] [Full Text] [Related]

  • 42. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R.
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [Abstract] [Full Text] [Related]

  • 43. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 44. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [Abstract] [Full Text] [Related]

  • 45. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR.
    Biol Psychiatry; 2006 Jun 01; 59(11):1061-4. PubMed ID: 16769295
    [Abstract] [Full Text] [Related]

  • 46. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S.
    Alcohol Clin Exp Res; 2010 Oct 01; 34(10):1822-31. PubMed ID: 20626727
    [Abstract] [Full Text] [Related]

  • 47. Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder.
    Vieta E, Suppes T, Ekholm B, Udd M, Gustafsson U.
    J Affect Disord; 2012 Dec 15; 142(1-3):36-44. PubMed ID: 23062763
    [Abstract] [Full Text] [Related]

  • 48. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder.
    Weiser M, Burshtein S, Gershon AA, Marian G, Vlad N, Grecu IG, Tocari E, Tiugan A, Hotineanu M, Davis JM.
    Bipolar Disord; 2014 Jun 15; 16(4):441-7. PubMed ID: 24712840
    [Abstract] [Full Text] [Related]

  • 49. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
    Suppes T, Eudicone J, McQuade R, Pikalov A, Carlson B.
    J Affect Disord; 2008 Apr 15; 107(1-3):145-54. PubMed ID: 17904226
    [Abstract] [Full Text] [Related]

  • 50. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
    Am J Psychiatry; 2005 Jul 15; 162(7):1281-90. PubMed ID: 15994710
    [Abstract] [Full Text] [Related]

  • 51. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD, Sajatovic M, Tafesse E, Wang RH.
    Ann Clin Psychiatry; 2009 Jul 15; 21(1):3-16. PubMed ID: 19239828
    [Abstract] [Full Text] [Related]

  • 52. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N, Severus WE, Greil W.
    Int Clin Psychopharmacol; 2007 May 15; 22(3):125-31. PubMed ID: 17414737
    [Abstract] [Full Text] [Related]

  • 53. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
    Fajutrao L, Paulsson B, Liu S, Locklear J.
    Clin Ther; 2009 Jun 15; 31 Pt 1():1456-68. PubMed ID: 19698903
    [Abstract] [Full Text] [Related]

  • 54. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
    Bowden CL, Collins MA, McElroy SL, Calabrese JR, Swann AC, Weisler RH, Wozniak PJ.
    Neuropsychopharmacology; 2005 Oct 15; 30(10):1932-9. PubMed ID: 15956987
    [Abstract] [Full Text] [Related]

  • 55. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
    Tohen M, Sutton VK, Calabrese JR, Sachs GS, Bowden CL.
    J Affect Disord; 2009 Jul 15; 116(1-2):43-50. PubMed ID: 19054570
    [Abstract] [Full Text] [Related]

  • 56. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M.
    Int J Neuropsychopharmacol; 2008 Jun 15; 11(4):445-52. PubMed ID: 18346292
    [Abstract] [Full Text] [Related]

  • 57. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ, Lee YJ, Lee YJ, Cho SJ.
    J Affect Disord; 2014 Mar 15; 157():33-40. PubMed ID: 24581825
    [Abstract] [Full Text] [Related]

  • 58. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.
    J Clin Psychiatry; 2004 Mar 15; 65(3):432-41. PubMed ID: 15096085
    [Abstract] [Full Text] [Related]

  • 59. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
    Szegedi A, Durgam S, Mackle M, Yu SY, Wu X, Mathews M, Landbloom RP.
    Am J Psychiatry; 2018 Jan 01; 175(1):71-79. PubMed ID: 28946761
    [Abstract] [Full Text] [Related]

  • 60. The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.
    Missio G, Moreno DH, Fernandes F, Bio DS, Soeiro-de-Souza MG, Rodrigues dos Santos D, David DP, Costa LF, Demétrio FN, Moreno RA.
    Trials; 2013 Jun 27; 14():190. PubMed ID: 23805994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.